OBJECTIVE: This paper aims to review the literature systematically on warfarin adherence in
patients with atrial fibrillation and to assess the anticoagulation control focused on patient …

The world's population is ageing, with the number of those over 60 years expected to
represent a fifth of the total population by 2050. Increases in chronic long-term health …

The prevalence of Alzheimer's disease (AD) has increased with the fast growing of aging
population, thereby posing great challenges to provision of care for AD patients …

Thromboembolic events are associated with high mortality and morbidity indexes. In this
context, warfarin is the most widely prescribed oral anticoagulant agent for preventing and …

Purpose Warfarin is an affordable drug used for numerous indications, and still a favorable
choice for patients with a history of bleeding from direct oral anticoagulants or presence of …

Despite the effectiveness of warfarin in extended anticoagulation, its narrow therapeutic
index requires frequent dose adjustments and careful patient monitoring. Thus, we aimed to …

Background The use of warfarin in patients with non-valvular atrial fibrillation (NVAF) can be
challenging. In this study, we evaluate the time in therapeutic range (TTR), health-related …

Objective This study was designed to evaluate the efficacy of remote medication
management of rivaroxaban by pharmacists for geriatric patients with nonvalvular atrial …

Background and aim The effect of anticoagulation control on overall Health-Related Quality
of Life (HRQoL) in patients taking warfarin in Malaysia has not been explored yet. Therefore …

Poor adherence to warfarin treatment is a contributor to poor quality of treatment, which
increases the risk of bleeding and thromboembolic events. This study aims to evaluate the …